
Commentary|Articles|November 2, 2026
AAO 2026 recap: Christopher J. Rapuano, MD, on the meeting's themes
Author(s)Kassi Filkins, Christopher J. Rapuano, MD
Fact checked by: Tracy Ann Politowicz
Christopher J. Rapuano, MD, discusses emergency eye care access, retinal advances, and responsible AI use in ophthalmology.
Advertisement
Advertisement
Timely access to care for sight-threatening eye injuries, therapies aimed at preserving and restoring vision in
Related to this article

Jayakrishna Ambati, MD, discusses phase 2 K8 findings in geographic atrophy, inflammasome targeting and K8 dosing and delivery.

Esen Akpek, MD, discusses how a systemic Sjögren disease therapy could change dry eye screening, referral and trial end points.

Six instructional courses at this year's congress in Florence follow artificial intelligence through retinal imaging, drug development, geographic atrophy care, and robotic surgery.

Josef Huemer, MD, discusses retinal changes linked to atrial fibrillation and what they mean for eye care clinicians.

Katherine Talcott, MD, discusses phase 2 VERONA findings on the vorolanib intravitreal insert in previously treated DME.

Kiril Kiprovski, MD, of NYU Langone shares clinical clues and bedside tests for spotting Lambert-Eaton myasthenic syndrome.
Advertisement
Advertisement


